InsiderDB

CVS Health (CVS)

Healthcare · Medical - Healthcare Plans

33 members of Congress have disclosed 100 trades in CVS Health (CVS) since 2014: 46 buys and 54 sales. The most recent was disclosed on Nov 5, 2026. 2 trades were made by members of a committee that oversees CVS Health's industry.

Trades disclosed
100
Members trading
33
Buys / sells
46 / 54
Reported value
$1.1M–$3.6M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow CVS

Research connections

Patterns in the available disclosures. Each source has its own timing and reporting limits.

What else is happening at CVS

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. CVSInsider purchase·SEC EDGAR

    CVS: Shah Prem S reported buying shares

    1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.

    Public: Nov 6, 2026, 4:41 PM ESTEvent / period: Nov 6, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. CVSFinancial report·SEC EDGAR

    CVS: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 4, 2026, 6:37 AM ESTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. CVSCompany announcement·SEC EDGAR

    CVS: Company disclosure

    Filed 8-K for an event or period dated 2026-11-04. Company disclosure.

    Public: Nov 4, 2026, 6:34 AM ESTEvent / period: Nov 4, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  4. CVSCompany announcement·SEC EDGAR

    CVS: Financial results

    Filed 8-K for an event or period dated 2026-11-04. Financial results.

    Public: Nov 4, 2026, 6:31 AM ESTEvent / period: Nov 4, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  5. CVSRegulatory notice·Federal Register

    Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure

    The Department is issuing a final regulation that will require providers of pharmacy benefit management services and affiliated providers of brokerage and consulting services to disclose information about their compensation to fiduciaries of large, self-insured group health plans subject to the Employee Retirement Income Security Act (ERISA). Pharmacy spending is a major driver of overall healthcare costs for employers and is growing faster than medical and surgical spending. These disclosure requirements apply for purposes of ERISA's statutory prohibited transaction exemption for service arrangements under section 408(b)(2). These disclosures are needed so that fiduciaries can assess the reasonableness of contracts or arrangements with these service providers, including the reasonableness of the service providers' compensation. As directed in section 12 of President Trump's Executive Order 14273, Lowering Drug Prices by Once Again Putting Americans First, the Department is issuing this rule to improve employer health plan transparency into the direct and indirect compensation received by pharmacy benefit managers. This final rule will affect sponsors and other fiduciaries of large, self-insured group health plans and certain service providers to such plans.

    Public: Nov 2, 2026Event / period: Jan 4, 2027Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Committee overlaps

Trades by members of a committee that oversees CVS Health's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded CVS

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.